Martin Shkreli is still behind bars for a variety of offenses, including security fraud, and is scheduled to be freed in September 2023.
Martin Shkreli is a former hedge fund manager and convicted felon in the United States. He is the co-founder and former CEO of the pharmaceutical companies Retrophin and Turning Pharmaceuticals, as well as Elea Capital, MSMB Capital Management, and MSMB Healthcare.
Shkreli is currently serving time in jail for fraud, and a federal judge has denied his plea to be released from probation early for the second time. However, the general public is inquiring if Martin Shkreli is still in jail for some reason.
Where Is Martin Shkreli Now in 2022?
Shkreli is being imprisoned in a federal prison in Allenwood, Pennsylvania, where he is being held in a low-security facility.
U.S. District Judge Kiyo Matsumoto recently dismissed a plea for release from prison based on mental health concerns. According to reports, the former Pharma CEO claimed that his mental health had “taken a harsh toll.” However, the judge stated that he had failed to establish a convincing basis to be released from prison sooner.
Shkreli, 37, now suffers from asthma and has completed his seven-year sentence in a Pennsylvania low-security jail. He said that his immune system had been weakened by his COVID-19 condition, which came with restricted interaction with people and his diet of peanut-butter-and-jelly sandwiches, and that this had increased his risk of contracting the disease. In 2023, he is scheduled to be released.
Martin Shkreli Jail Time Sentence And Release Date
Shkreli was sentenced to seven years in jail in 2017 for misrepresenting investors about the performance of two hedge funds he ran, withdrawing more money from those funds than he was entitled to, and hiding his ownership of some of Retrophin’s stock.
After losing $7.3 million as part of his judgment, Shkreli is scheduled to be released in September 2023.
Shkreli made headlines after gaining control of a medicine used to treat an illness that can occur in people with AIDS, malaria, and cancer, and raising the price from $13.50 to $750 per lozenge.
What Happened To Martin Shkreli?
In 2015, the pharma CEO attempted to boost the price of a certain medication, Daraprim, which is used to treat HIV/AIDS patients. The original price was $13.50 per tablet, and he planned to raise it to $750. He was then banned from Twitter for harassing Lauren Duca, a Teen Vogue writer, among other things.
Individuals were so angry with him that he ended up on a Google search for “worst people.” However, he is currently serving time in prison for defrauding a Ponzi scheme. Ponzi scheme fraud is referred to as “paying out one investor’s debt with the money of other investors.”
Furthermore, Martin co-founded MSMB Capital and MSMB Healthcare, where he brought in some unscrupulous investors and paid off investors from his Retrophin organization. He was found guilty and sentenced to prison for conducting two security frauds.